[
    [
        {
            "time": "",
            "original_text": "药明康德净利润首下降近18%，CRO烧钱严重再向投资者伸手 盈利能力下降",
            "features": {
                "keywords": [
                    "药明康德",
                    "净利润",
                    "下降",
                    "CRO",
                    "烧钱",
                    "投资者",
                    "盈利能力"
                ],
                "sentiment_score": -0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德净利润首下降近18%，CRO烧钱严重再向投资者伸手 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]